Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/11/2023 | eFFECTOR Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 33.8k | $0.52 | $17.6k | | 08/11/2023 |
05/15/2023 | eFFECTOR Therapeutics, Inc. | | Grant | Common Stock | 6.4k | $0.46 | $2.9k | | 05/15/2023 |
01/17/2023 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 1000k | $0.47 | $470k | | 01/17/2023 |
11/15/2022 | eFFECTOR Therapeutics, Inc. | | Grant | Common Stock | 6k | $0.47 | $2.8k | | 11/15/2022 |
06/20/2022 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 520.7k | $1.49 | $775.8k | | 06/20/2022 |
06/14/2022 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15.8k | $1.30 | $20.5k | | 06/14/2022 |
06/07/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 20k | $1.37 | $27.4k | | 06/07/2022 |
05/13/2022 | eFFECTOR Therapeutics, Inc. | | Grant | Common Stock | 1.8k | $1.53 | $2.8k | | 05/13/2022 |
01/20/2022 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 520.7k | $6.65 | $3.5M | | 01/20/2022 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Common Stock | 512.3k | $0.00 | $0 | By Trust | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Common Stock | 50k | $10.00 | $500k | By Trust | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Common Stock | 193.1k | $0.00 | $0 | | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 33.8k | $0.52 | $17.6k | | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 217.3k | $0.73 | $158.6k | | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 619k | $1.14 | $705.7k | | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 144.9k | $1.14 | $165.1k | | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 289.7k | $1.66 | $480.9k | | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Earn-out Right | 75.5k | $0.00 | $0 | By Trust | 08/25/2021 |
08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Earn-out Right | 220.6k | $0.00 | $0 | | 08/25/2021 |
06/10/2021 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 10.5k | $6.55 | $68.8k | | 06/10/2021 |
06/10/2020 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 4.5k | $2.07 | $9.3k | | 06/10/2020 |
06/13/2019 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15k | $0.64 | $9.5k | | 06/13/2019 |
06/13/2018 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15k | $2.70 | $40.5k | | 06/13/2018 |
06/15/2017 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15k | $2.15 | $32.2k | | 06/15/2017 |
06/01/2016 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Common Stock | 7.5k | $0.00 | $0 | | 06/01/2016 |
07/23/2015 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option ( Right to Buy) | 15k | $13.02 | $195.3k | | 07/23/2015 |
07/23/2015 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option ( Right to Buy) | 6.1k | $13.02 | $79.5k | | 07/23/2015 |
02/25/2015 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option ( Right to Buy) | 18.9k | $13.40 | $253.2k | | 02/25/2015 |
05/29/2014 | GenMark Diagnostics, Inc. | GNMK | Grant | Common Stock | 5.7k | $0.00 | $0 | | 05/29/2014 |
05/22/2013 | GenMark Diagnostics, Inc. | GNMK | Grant | Common Stock | 14.9k | $0.00 | $0 | | 05/22/2013 |
06/13/2012 | GenMark Diagnostics, Inc. | GNMK | Grant | Stock Option (Right to Buy) | 25k | $4.34 | $108.5k | | 06/13/2012 |